BioDuro in peptide expansion

BioDuro has announced the opening of a kilogram-scale, solid-phase peptide synthesis scale-up laboratory at its Shanghai Zhangjiang High-tech Park campus in China, in response to growing demand. The company added that this is new facility further enhances its capabilities to meet increasing demand for scalable peptide manufacturing. 

Key features include automated solid phase peptide synthesisers, cleavage systems and freeze-drying equipment, supporting synthesis scale-up to 800 mmol. It is designed to produce a wide range of peptide molecules, including linear and cyclic peptides and various peptide-drug conjugates (PDCs). 

The facility is designed to complement the peptide discovery synthesis centre at BioDuro’s Beijing campus, which focuses on early-stage R&D, enabling projects to be integrated from discovery to development. The chemistry teams at both campuses specialize in solid- and liquid-phase synthesis. The firm’s peptide platform also includes biology and DMPK services.